A Post-marketing Surveillance Study to Assess the Safety of Cervarix (GlaxoSmithKline [GSK] Biologicals' Human Papillomavirus [HPV] -16/18 Vaccine), When Administered According to the Approved Prescribing Information (PI) in Korea

Clinical trial NCT03671369 · COMPLETED

Trial details

NCT number: NCT03671369
Sponsor: GlaxoSmithKline
Status: COMPLETED
Study type: OBSERVATIONAL

Neoplasms, Rectal

Start date: 2018-10-02
Primary completion: 2020-12-01
Enrollment: 670

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.